SavedAdd your journal

Journals / Genel Tıp Dergisi / 1998 / Cilt: 8 - Sayı: 1

The frequency of anti-HCV positivity in whom applied to policlinics of internal medicine at Hospital of Harran University

Harran Üniversitesi Hastanesi dahiliye polikliniğine başvuranlarda anti-HCV pozitiflik sıklığı

Yaşar NAZLIGÜL
Mahmut DALMAZ
Hüseyin VURAL
Hüseyin USLUSOY
Ali COŞKUN
Pages
5–7
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant increase in anti-HCV positivity with aging.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, it was aimed to determine the frequency of anti-HCV positivity in whom applied to policlinics of internal medicine at Hospital of Harran University.
📊
Key Findings & Data:Methods: Blood samples were taken from patients who were not in any risk group and had no history of jaundice. 947 samples were investigated for anti-HCV antibodies.
💡
Conclusion & Impact:There was a significant increase in anti-HCV positivity with aging.
🔬Design:Research Article
📍Scope:947 samples
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, it was aimed to determine the frequency of anti-HCV positivity in whom applied to policlinics of internal medicine at Hospital of Harran University. Methods: Blood samples were taken from patients who were not in any risk group and had no history of jaundice. 947 samples were investigated for anti-HCV antibodies. Results: In 1.9% of 947 persons, anti-HCV antibodies were detected. Conclusion: Hepatitis C infection was more common than in European countries and other regions of Turkey. There was a significant increase in anti-HCV positivity with aging.

Özet

Amaç: Bu çalışmada Harran Üniversitesi Hastanesi dahiliye polikliniğine başvuranlarda anti-HCV pozitiflik sıklığının belirlenmesi amaçlandı. Yöntem; Bilinen herhangi bir risk grubuna girmeyen iktersiz hastaların serumları anti-HCV antikorları yönünden incelendi. Bulgular: Tetkik edilen 947 serumun 18'inde (% 1.9) anti-HCV antikoru bulundu. Sonuç: Bulunan anti-HCV pozitiflik sıklığı, Avrupa ülkelerinde ve Türkiye'nin diğer yerlerinde bulunan oranlardan fazladır ve yaşla artış göstermektedir.

🔖

Cite This Article

NAZLIGÜL, Y., DALMAZ, M., VURAL, H., USLUSOY, H., COŞKUN, A. (1998). The frequency of anti-HCV positivity in whom applied to policlinics of internal medicine at Hospital of Harran University. Genel Tıp Dergisi, Cilt: 8 - Sayı: 1, 5–7. https://ajindex.com/articles/225220

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Kılıçturgay K. Akut viral hepatitler. Aktüel Tıp Derg 1997;2:19-23. Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol 1993;17 Suppl 3:67-71. Çakaloğlu Y. Kronik viral hepatitislerin tedavisi: Yeni yaklaşımlar. Aktüel Tıp Derg 1997;2:25-9.
  2. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000. Sönmez E. New approaches to hepatitis C virus infection. Turgut Özal Tıp Merkezi Derg 1995;2:383-90.
  3. Dökmetaş HS, Türkay C, Dökmetaş İ, İçağasıoğlu S, Topçu S, Poyraz Ö. Kronik karaciğer hastalıklarının etyolojisinde hepatit B, C ve delta virüslerinin rolü. Cumhuriyet Üniv Tıp Fak Derg 1995;17:261-4. Mabrouk GM. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma. Dis Markers 1997;12:177-82.
  4. Yönetici N, Akarsu US, Ersöz G, İşler M, Batur Y. Hepatosellüler kanser etyolojisinde hepatit virusları. Turk Gastroenterol 1996;7:127-30. Triverdi M. Newly diagnosed hepatitis C, lack of symptoms doesn't mean lack of progression. Postgrad Med 1997;102:95-8.
  5. Bayraktar Y, Colastoni A, De Maria N, Vanthiel DH. Hepatitis C: Current issues and the potential for feature progress. Turk Gastroenterol 1995;6:303-13. Degos F. Epidemiology of hepatitis C virus in Europe. FEMS Microbiol Rev 1994;14:267-72.
  6. Oshita M, Hayashi N, Kashara A, Yuki N, Takehara T, Hagiwara H, et al. Prevalence of hepatitis C virus in family members of patients with hepatitis C. J Med Virol 1993;41:251-5.
  7. Osella RA, Misciagna G, Leone A, Leo DA, Fiore G. Epidemiology of hepatitis C virus infection in an area of Southern Italy. J Hepatol 1997;27:30-5.
  8. Helvacı M, Çetemen A, Arus E, İsenlik S. Hepatit C. Yeni Tıp Derg 1997;14:223-4.
  9. Huraib S, Al Rashed R, Aldress A, Aljefry M, Arif M, Al Faleh FA. High prevalence of and risk factors for hepatitis C in hemodialysis patient in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 1995;10:470-4. Huaghan CC. Hepatitis in patients with end stage renal disease. J Gastroenterol Hepatol 1997;12:236-41.
  10. Struve J, Aransson B, Frenning B, Forsgren M, Weiland O. Prevalence of antibodies against hepatitis C virus infection among health care worker in Stockholm. Scand J Gastroenterol 1994;29:360-2.
  11. Paydas S, Aksu HS, Paydas S, Burgut R, Sagliker Y. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease. Br J Clin Pract 199